GE sells BioPharma business to CEO's former company
General Electric selling Danaher Corporation, its biopharma business
GE to sell biopharma business to Danaher for $21B - Boston Business Journal
Danaher Corporation: General Electric to Sell Biopharma Unit for $21.4 Billion
How to Trade GE Stock After Earnings Surge - TheStreet
GE sells biopharma unit for US$21 billion | CTV News
GE Deal With Danaher Shows Culp Is All About the Balance Sheet - Bloomberg
GE to sell life sciences business for $21.4 billion | Crain's Chicago Business
GE sells biopharma unit for $21 billion | The Seattle Times
GE Healthcare leaves GE, looks to 'next chapter'
GE sells biopharma unit to Danaher for $21.4B
GE sells BioPharma business to CEO's former company for $21.4 billion | CNN Business
GE Sells Coveted $21 Billion BioPharma to Pay Down Crippling Debt Load
GE To Sell Its BioPharma Unit For $21.4 Billion To Danaher | GE News
GE to sell BioPharma business to Danaher for $21.4B | Fox Business
GE agrees to sell BioPharma unit to Danaher for US$21.4 billion
GE sells biopharma drug business to Danaher for $21.4 billion
General Electric — Wikipédia
GE: The Biopharma Deal Is Nearing Completion
Debt-saddled GE sells off BioPharma business to Danaher for $21.4B - MedCity News
GE sells biopharma drug business to Danaher for $21.4 bn, Energy News, ET EnergyWorld
Danaher Corporation: General Electric to Sell Biopharma Unit for $21.4 Billion
Danaher Selling Off Some Businesses to Sartorius for $750M, Tying the Deal to GE Biopharma Acquisition
GE sells jet-leasing unit to AerCap for $30 bn
General Electric Sells Biopharma Unit for $21 Billion | | 2news.com
GE Sells Coveted BioPharma Unit to Pay Down $21 Billion in Crippling Debt
GE Healthcare float sunk in favour of Danaher deal | Evaluate
GE to Sell Its Biotech Business to Danaher for $21 Billion - WSJ
